RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+50.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.65B
AUM Growth
+$3.65B
Cap. Flow
+$447M
Cap. Flow %
12.25%
Top 10 Hldgs %
23.51%
Holding
147
New
14
Increased
83
Reduced
11
Closed
4

Sector Composition

1 Healthcare 92.16%
2 Consumer Staples 1.09%
3 Consumer Discretionary 0.54%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PHAS
126
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$5.26M 0.14% 1,143,925 +18,925 +2% +$87.1K
GRTX
127
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$4.05M 0.11% 567,552 +67,552 +14% +$482K
NARI
128
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.88M 0.11% +80,000 New +$3.88M
CO
129
DELISTED
Global Cord Blood Corporation
CO
$2.87M 0.08% 925,000
ACRS icon
130
Aclaris Therapeutics
ACRS
$209M
$2.66M 0.07% 1,644,015 +44,015 +3% +$71.3K
FPRX
131
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.48M 0.07% 406,729 +6,729 +2% +$41K
CYTK icon
132
Cytokinetics
CYTK
$4.23B
$1.83M 0.05% +77,417 New +$1.83M
NBRV
133
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$720K 0.02% 1,067,664 +17,664 +2% +$11.9K
BMY.RT
134
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$663K 0.02% 185,150
TMO icon
135
Thermo Fisher Scientific
TMO
$186B
-17,500 Closed -$4.96M
AXNX
136
DELISTED
Axonics, Inc. Common Stock
AXNX
-125,000 Closed -$3.18M
XLRN
137
DELISTED
Acceleron Pharma Inc.
XLRN
-17,500 Closed -$1.57M
FTSV
138
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-447,400 Closed -$42.7M